Hasi saioa elementu hau beste hizkuntza batzuetan ikusteko
In Copyright (leiho berrian irekiko da)

Effect of genetic variants of the ABCC2 transporter on bioavailability of mycophenolic acid in renal-transplant patients

Mycophenolic acid (MPA) displays variable pharmacokinetics (PK). It is metabolized by UGTs to MPA-glucuronide which is subject to enterohepatic recirculation. Biliary and kidney excretion involves multidrug resistant protein 2 (MRP2) coded by ABCC2. We assessed steady-state PK of MPA in renal allograft recipients in respect to donor and recipient ABCC2 genotypes, along with other clinical covariat…

Erakunde hornitzailearen webgunean ikusi (leiho berrian irekiko da)

Laguntzaileak

  • Božina, Nada

Sortzailea

  • Lalić, Zdenka

Argitaletxea

  • University of Zagreb. Faculty of Pharmacy and Biochemistry.

Gaia

  • BIOMEDICINE AND HEALTHCARE. Pharmacy. Pharmacy.
  • Biotechnology. Genetic engineering. Products of cloning
  • mycophenolic acid
  • pharmacokinetics
  • pharmacogenetics
  • MRP2/ABCC2
  • renal transplant patients
  • cyclosporine
  • tacrolimus

Elementu mota

  • info:eu-repo/semantics/doctoralThesis
  • text

Data

  • 2015-12-03
  • 2015-12-03